Vagus Nerve Stimulation (VNS) Therapy

DEVICE3 trials

Sponsors

University of Medicine and Dentistry of New Jersey, Cyberonics, Inc., LivaNova

Conditions

Drug Resistant EpilepsyEpilepsyFibromyalgiaSeizures

Phase 1

Vagus Nerve Stimulation for Treating Adults With Severe Fibromyalgia

CompletedNCT00294281

University of Medicine and Dentistry of New JerseyFibromyalgia

Start: 2006-10-31End: 2010-06-30Updated: 2011-09-20

Phase 4

Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures

TerminatedNCT01118455

Cyberonics, Inc.Epilepsy

Start: 2004-10-31End: 2010-01-31Updated: 2014-06-26

Unknown Phase

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

CompletedNCT03529045

LivaNovaDrug Resistant Epilepsy, Epilepsy, Seizures

Start: 2018-02-05End: 2024-09-11Updated: 2024-11-22

Related Papers

Vagus Nerve Stimulation in Failed Epilepsy Surgery: 36 Month Outcomes From the CORE-VNS Study

medRxiv2026-04-22

Vagus nerve stimulation in Lennox–Gastaut syndrome: Twenty‐four‐month data and experience from the <scp>CORE</scp>‐<scp>VNS</scp> study

Epilepsia2025-02-0810 citations

Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry

BMJ Neurology Open2021-12-0118 citations